Experts Claim Proposed Californian Cannabis Regulations Could Put Medical Cannabis Users at Risk of Infection

On July 13, the Bureau of Cannabis Control (BCC), which regulates medicinal and commercial cannabis in California, proposed a new list of state regulations, which cover a huge range of licensing and safety issues.  Industry experts were however surprised to see that these proposals do not include a requirement for a Total Yeast and Mold Count (TYMC). The lack of this criterion means that cannabis products heavily contaminated with fungi and fungal toxins could potentially pass testing and make it on to the market. Ignoring the advice of the California Cannabis Industry Association’s (CCIA) Quality Control Committee (QCC), the BCC’s proposal instead favors strain specific testing using PCR-based methods. This screening method is inherently far more focused than TYMC and as such can miss contamination from fungi that are not included in the target list. 

Through conversation with CCIA members, Analytical Cannabis have learned that the lack of a TYMC requirement could put users at risk of infection. 

[Please click the link to view the full article]